Novo Nordisk Walks Back Comments on Addiction Testing
Pharmaceutical giant Novo Nordisk is walking back comments about testing GLP-1 drugs for use in addiction treatment.
Novo Nordisk to Test GLP-1 Drugs Against Addiction
Novo Nordisk, maker of Ozempic and Wegovy, says they will start testing GLP-1 drugs for use in treating addiction.